Keudell Bristol Myers Squibb CO Transaction History

Keudell

$366 Million
Q3 2024

A detailed history of Keudell transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Keudell holds 22,703 shares of BMY stock, worth $1.32 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

22,703

Previous 21,245 6.86%

Holding current value

$1.32 Million

Previous $882,000 33.11%

% of portfolio

0.32%

Previous 0.26%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$39.66 - $51.75 $57,824 - $75,451	1,458 Added 6.86%	22,703 $1.17 Million
Q2 2024 Jul 16, 2024	BUY	$40.25 - $52.99 $192,918 - $253,981	4,793 Added 29.13%	21,245 $882,000
Q1 2024 May 07, 2024	BUY	$47.98 - $54.4 $264,417 - $299,798	5,511 Added 50.37%	16,452 $892,000
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $12,216 - $14,578	252 Added 2.36%	10,941 $561,000
Q3 2023 Oct 18, 2023	SELL	$57.89 - $64.73 $49,785 - $55,667	-860 Reduced 7.45%	10,689 $620,000
Q2 2023 Jul 20, 2023	SELL	$63.71 - $70.74 $2,930 - $3,254	-46 Reduced 0.4%	11,549 $738,000
Q1 2023 Apr 18, 2023	SELL	$65.71 - $74.53 $34,957 - $39,649	-532 Reduced 4.39%	11,595 $803,000
Q4 2022 Jan 20, 2023	SELL	$68.48 - $81.09 $139,562 - $165,261	-2,038 Reduced 14.39%	12,127 $0
Q3 2022 Oct 12, 2022	SELL	$0.13 - $76.84 $345 - $204,471	-2,661 Reduced 15.81%	14,165 $1.01 Million
Q2 2022 Jul 18, 2022	SELL	$72.62 - $79.98 $151,703 - $167,078	-2,089 Reduced 11.04%	16,826 $1.3 Million
Q1 2022 Apr 18, 2022	BUY	$61.48 - $73.72 $85,149 - $102,102	1,385 Added 7.9%	18,915 $1.38 Million
Q4 2021 Feb 08, 2022	BUY	$53.63 - $62.52 $221,545 - $258,270	4,131 Added 30.83%	17,530 $1.09 Million
Q3 2021 Oct 20, 2021	SELL	$59.17 - $69.31 $47,395 - $55,517	-801 Reduced 5.64%	13,399 $793,000
Q2 2021 Jul 13, 2021	SELL	$61.91 - $67.42 $5,509 - $6,000	-89 Reduced 0.62%	14,200 $949,000
Q1 2021 Apr 13, 2021	SELL	$59.34 - $66.74 $24,388 - $27,430	-411 Reduced 2.8%	14,289 $902,000
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $124,314 - $140,870	-2,153 Reduced 12.78%	14,700 $912,000
Q3 2020 Oct 20, 2020	SELL	$57.43 - $63.64 $65,987 - $73,122	-1,149 Reduced 6.38%	16,853 $1.02 Million
Q2 2020 Jul 14, 2020	BUY	$54.82 - $64.09 $68,908 - $80,561	1,257 Added 7.51%	18,002 $1.06 Million
Q1 2020 Apr 20, 2020	SELL	$46.4 - $67.43 $20,648 - $30,006	-445 Reduced 2.59%	16,745 $933,000
Q4 2019 Jan 29, 2020	BUY	$49.21 - $64.19 $291,520 - $380,261	5,924 Added 52.58%	17,190 $1.1 Million
Q2 2019 Aug 23, 2019	BUY	$44.62 - $49.34 $502,688 - $555,864	11,266 New	11,266 $521,000
Q2 2019 Aug 21, 2019	SELL	$44.62 - $49.34 $500,904 - $553,890	-11,226 Closed	0 $0
Q1 2019 Aug 21, 2019	BUY	$45.12 - $53.8 $506,517 - $603,958	11,226 New	11,226 $536,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keudell, based on Form 13F filings with the SEC.

News

Stay updated on Keudell with notifications on news.

Account